Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
J Infect Dis ; 223(2): 297-305, 2021 02 03.
Artículo en Inglés | MEDLINE | ID: mdl-32561912

RESUMEN

BACKGROUND: Interleukin-10 (IL-10) has been implicated as the major cytokine responsible for the modulation of parasite-specific responses in filarial infections; however, the role of other IL-10 superfamily members in filarial infection is less well studied. METHODS: Peripheral blood mononuclear cells from loiasis patients were stimulated with or without filarial antigen. Cytokine production was quantified using a Luminex platform and T-cell expression patterns were assessed by flow cytometry. RESULTS: All patients produced significant levels of IL-10, IL-13, IL-5, IL-4, and IL-9 in response to filarial antigen, indicating a common infection-driven response. When comparing microfilaria (mf)-positive and mf-negative patients, there were no significant differences in spontaneous cytokine nor in parasite-driven IL-10, IL-22, or IL-28a production. In marked contrast, mf-positive individuals had significantly increased filarial antigen-driven IL-24 and IL-19 compared to mf-negative subjects. mf-positive patients also demonstrated significantly higher frequencies of T cells producing IL-19 in comparison to mf-negative patients. T-cell expression of IL-19 and IL-24 was positively regulated by IL-10 and IL-1ß. IL-24 production was also regulated by IL-37. CONCLUSION: These data provide an important link between IL-10 and its related family members IL-19 and IL-24 in the modulation of the immune response in human filarial infections. CLINICAL TRIALS REGISTRATION: NCT00001230.


Asunto(s)
Inmunomodulación , Interleucina-10/metabolismo , Interleucinas/metabolismo , Loa/inmunología , Loiasis/etiología , Loiasis/metabolismo , Adolescente , Adulto , Animales , Niño , Citocinas/biosíntesis , Susceptibilidad a Enfermedades , Femenino , Interacciones Huésped-Parásitos , Humanos , Masculino , Persona de Mediana Edad , Subgrupos de Linfocitos T/inmunología , Subgrupos de Linfocitos T/metabolismo , Células Th2/inmunología , Células Th2/metabolismo , Adulto Joven
2.
BMC Infect Dis ; 19(1): 146, 2019 Feb 13.
Artículo en Inglés | MEDLINE | ID: mdl-30760228

RESUMEN

BACKGROUND: Loiasis is a vector-borne parasitic disease due to Loa loa and transmitted to humans by tabanids of the genus Chrysops. Loiasis has been historically considered as the second or third most common reason for medical consultation after malaria, and a recent study has reported an excess mortality associated with the infection. However, the clinical impact of this filarial disease is yet to be elucidated, and it is still considered a benign disease eliciting very little attention. As a consequence of post-treatment severe adverse events occurring in individuals harboring very high Loa microfilarial loads, ivermectin is not recommended in onchocerciasis hypo-endemic areas that are co-endemic for loiasis. Without treatment, it is likely that the transmission of the disease and the morbidity associated with the infection will increase over time. This study aimed at investigating the long-term trends in prevalence and intensity of Loa loa infection in an area where no mass anti-filarial treatment has ever been distributed. METHODS: A cross-sectional survey was conducted in three communities of the Mbalmayo health district (Central Cameroon). All volunteers, males and females aged five years and above, underwent daytime calibrated thick blood smears (CTBS) to search for L. loa microfilariae (mf). A structured questionnaire was administered to assess the history of both loiasis related clinical signs and migration of enrollees. RESULTS: The prevalence of loiasis was 27.3% (95% CI: 22.3-32.9) in the three surveyed communities, with a mean mf density of 1922.7 (sd: 6623.2) mf/mL. Loa loa infection rate was higher amongst females than in males (p = 0.0001) and was positively associated with age of (OR = 1.018; p = 0.007). The intensity of infection was higher among males than in females (p < 0.0001), and displayed a convex in form trends with age groups. The follow up over 23 years revealed that both the rate and intensity of infection were similar to baseline. CONCLUSIONS: The prevalence and intensity of Loa loa infection 23 years on is stable over time, indicating that this filarial disease might be noncumulative as regarded till now.


Asunto(s)
Loiasis/epidemiología , Loiasis/etiología , Adulto , Animales , Camerún/epidemiología , Preescolar , Estudios Transversales , Femenino , Humanos , Loa/patogenicidad , Masculino , Persona de Mediana Edad , Morbilidad , Carga de Parásitos , Prevalencia
3.
Am J Trop Med Hyg ; 93(3): 607-11, 2015 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-26101271

RESUMEN

We retrospectively analyzed the background, clinical features, and treatment response of 50 cases of imported loiasis who presented between 2000 and 2014 to the Hospital for Tropical Diseases (HTD), London, United Kingdom. Of them, 29 were migrants from, and 21 were visitors to, countries where the disease is endemic. Clinical features differed between these groups. Migrants experienced fewer Calabar swellings (odds ratio [OR] = 0.12), more eye worm (OR = 3.4), more microfilaremia (OR = 3.5), lower filarial antibody levels, and lower eosinophil counts (P < 0.05 for all tests). Among 46 patients who were started on treatment at HTD, 33 (72%) received diethylcarbamazine (DEC) monotherapy as first-line treatment, and among 26 patients who were followed up after treatment, seven (27%) needed a second course of treatment. There were 46 courses of treatment with DEC, and 20 (43%) of them had reactions. All patients with microfilaremia > 3,000 microfilariae/mL and all those with an elevated C-reactive protein (CRP) (≥ 5 mg/L) before treatment had reactions (P = 0.10 and P = 0.01, respectively). These data suggest that monotherapy with DEC may not be the optimal treatment for patients with loiasis, particularly for those with a high microfilarial load.


Asunto(s)
Loiasis/etiología , Adulto , Dietilcarbamazina/uso terapéutico , Femenino , Filaricidas/uso terapéutico , Hospitales Especializados/estadística & datos numéricos , Humanos , Periodo de Incubación de Enfermedades Infecciosas , Loiasis/diagnóstico , Loiasis/tratamiento farmacológico , Loiasis/patología , Londres/epidemiología , Masculino , Estudios Retrospectivos , Migrantes/estadística & datos numéricos , Viaje
4.
MMWR Morb Mortal Wkly Rep ; 30(38): 479-80, 1981 Oct 02.
Artículo en Inglés | MEDLINE | ID: mdl-6792497
6.
Ann Trop Med Parasitol ; 99(5): 491-500, 2005 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-16004708

RESUMEN

No microfilariae are detectable in a significant percentage of those infected with the filarial worm Loa loa. While the probability of an infected individual becoming microfilaraemic is known to increase with age, the mechanisms underlying this trend are not well understood. Epidemiological data from an endemic village in central Cameroon were therefore explored, in an attempt to determine if, after taking into account any history of filaricidal treatment, the presence of Loa microfilaraemia in an individual was related to his/her gender, age, and/or exposure to the human-infective larvae of the parasite. An index of exposure, based on the monthly transmission potentials of the Chrysops in each of the main types of vegetation in a village and on the activity schedule of each inhabitant of the village, was developed. The results of the data analysis confirm that the acquisition of microfilaraemia is gender-dependent (males generally being more likely to be microfilaraemic than females), and indicate that, in males, a high level of exposure to infective larvae determines the shift from amicrofilaraemic to microfilaraemic status. They also indicate that filaricidal treatments have a long-lasting suppressive effect on Loa microfilaraemia, an observation that may have important implications for any strategy to limit the risk of Loa-associated encephalopathy following ivermectin treatment.


Asunto(s)
Loiasis/etiología , Microfilarias/aislamiento & purificación , Adolescente , Adulto , Distribución por Edad , Análisis de Varianza , Animales , Camerún/epidemiología , Enfermedades Endémicas , Exposición a Riesgos Ambientales/efectos adversos , Femenino , Filaricidas/uso terapéutico , Humanos , Ivermectina/uso terapéutico , Loa/aislamiento & purificación , Loiasis/epidemiología , Loiasis/transmisión , Masculino , Persona de Mediana Edad , Prevalencia , Salud Rural , Distribución por Sexo
7.
Klin Monbl Augenheilkd ; 222(3): 226-30, 2005 Mar.
Artículo en Alemán | MEDLINE | ID: mdl-15785986

RESUMEN

BACKGROUND: With increasing migration tropical diseases such as Loa loa infections are becoming more frequent in Europe. While the ocular diagnosis is usually straight forward, systemic work-up and treatment requires an interdisciplinary approach. We review the diagnostic and therapeutic work-up of ocular Loa loa infections based on a series of 4 cases that presented between 1998 and 2004. HISTORY AND SIGNS: The first symptoms in all cases were ocular irritations occurring 2 months to 8 years after a trip to West Africa. One case presented with a swollen upper eyelid without a visible worm. In three patients microfilariae were detected in the blood. THERAPY AND OUTCOME: In two cases visible subconjunctival worms could be removed under the slit lamp. Three cases required systemic treatment as inpatients while one case could be observed without systemic treatment. All 4 cases had a favourable outcome with complete eradication of the disease. CONCLUSION: Surgical removal of adult Loa loa worms from the subconjunctival space only improves the ocular symptoms. An interdisciplinary approach (ophthalmology, infectious disease and parasitology) for a systemic work-up and treatment is usually required.


Asunto(s)
Infecciones Parasitarias del Ojo/diagnóstico , Loa , Loiasis/diagnóstico , Adolescente , Adulto , Albendazol/administración & dosificación , Animales , Camerún , Terapia Combinada , Conjuntiva/parasitología , Conjuntiva/cirugía , Infecciones Parasitarias del Ojo/etiología , Infecciones Parasitarias del Ojo/terapia , Femenino , Humanos , Loiasis/etiología , Loiasis/terapia , Masculino , Microfilarias , Persona de Mediana Edad , Grupo de Atención al Paciente , Viaje
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA